Altamira Therapeutics Ltd.: In Vivo Data Presented at AHA Conference Demonstrates Altamira Therapeutics' SemaPhore mRNA Delivery Platform to Effectively Help Preserve Atherosclerotic Plaque Stability

• Animal study shows effective protection of mitochondria from oxidative damage and reduced plaque vulnerability in advanced atherosclerosis following treatment with SOD2 mRNA nanoparticles based on Altamira's

Related Keywords

United States ,Switzerland ,Bermuda ,American , ,Securities Exchange Commission ,Altamira Therapeutics Ltd View ,Securities Exchange ,American Heart Association Annual Scientific Sessions Chicago ,Altamira Therapeutics ,Michigan School ,Ann Arbor ,Superoxide Dismutase ,Securities Act ,Securities Exchange Act ,Altamira Therapeutic ,Altamira Therapeutic Annual Report ,Altamira ,Herapeutics ,Ivo ,Data ,Resented ,Conference ,Emonstrates ,Semaphore ,Rna ,Delivery ,Platform ,Ffectively ,Help ,Reserve ,Atherosclerotic ,Plaque ,Stability ,